Clinical Trial Update: Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing vaginal progesterone with intramuscular progesterone for preventing preterm birth in high-risk pregnant women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Hydroxyprogesterone caproate (intramuscular) (hydroxyprogesterone caproate)
• Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Ewha Womans University Mokdong Hospital | Conditions: Premature Birth | Phase 3 | Status: UNKNOWN